Therefore, the recent American Diabetes Association (ADA) guidelines have suggested that isCGM should be offered for diabetes management in patients with type 2 diabetes on multiple daily injections or continuous subcutaneous insulin infusion who are capable of using the devices safely [7]. Here, INS is linked to type 2 diabetes mellitus.